Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) PT at $583.83

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have earned an average recommendation of “Moderate Buy” from the twenty-one analysts that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $613.10.

A number of brokerages have recently commented on ISRG. Mizuho raised their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Evercore ISI raised their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Robert W. Baird boosted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th.

Intuitive Surgical Trading Down 1.4 %

Shares of ISRG stock opened at $571.88 on Monday. The company’s fifty day simple moving average is $550.40 and its 200-day simple moving average is $509.43. Intuitive Surgical has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market cap of $203.69 billion, a PE ratio of 89.22, a P/E/G ratio of 5.52 and a beta of 1.39.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 28,843 shares of company stock worth $15,357,560. 0.90% of the stock is owned by insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several large investors have recently made changes to their positions in ISRG. Massachusetts Financial Services Co. MA bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $558,807,000. International Assets Investment Management LLC lifted its position in Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after purchasing an additional 1,088,415 shares during the period. FMR LLC lifted its position in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB raised its position in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after acquiring an additional 552,058 shares during the period. Finally, Strategic Financial Concepts LLC raised its position in shares of Intuitive Surgical by 50,740.8% in the 4th quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock valued at $163,202,000 after acquiring an additional 312,056 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.